abstract |
The present invention provides a lipolysis composition comprising deoxycholic acid or pharmaceutically acceptable salts thereof and a pharmaceutical composition for preventing or treating obesity, comprising, for example, topical obesity. The pharmaceutical composition of the present invention does not cause a precipitate even at a low pH compared to a conventional DCA-containing preparation, thus not only showing excellent storage stability, but also minimizing side effects such as a burning sensation, inflammations, etc. in a site of administration. |